83 results
Page 3 of 5
8-K
EX-99.1
m8oyok
13 May 21
Windtree Therapeutics Reports First Quarter 2021 Financial Results and Provides Key Business Updates
7:34am
8-K
EX-99.1
g9ukzx8u as
29 Mar 21
Windtree Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides Key Business Updates
5:26pm
424B5
wlk9k14qstnsi 02j3o
24 Mar 21
Prospectus supplement for primary offering
5:14pm
424B5
elk5xyg
22 Mar 21
Prospectus supplement for primary offering
4:39pm
8-K
EX-99.1
qg9jy4nn16h0
16 Nov 20
Windtree Therapeutics Reports Third Quarter 2020
7:40am
8-K
EX-99.1
6x2q97qe5jopzvh0j
1 Oct 20
Windtree Announces First Patient Dosed in Phase 2 Study of Istaroxime for the Acute Treatment of Early Cardiogenic Shock in Heart Failure Patients
7:36am
8-K
EX-99.1
ere ygszscijg9v2u
29 Sep 20
Other Events
7:37am
8-K
EX-99.1
m01 l3868ckurgbzv
14 Aug 20
Windtree Therapeutics Reports Second Quarter 2020 Financial Results and Provides Key Business Updates
6:07am
8-K
EX-99.2
g6mxrp1hqqeh5r7
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm
8-K
EX-99.1
3tgwn idi24nexd
22 May 20
Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market
5:22pm
424B4
ldbah
21 May 20
Prospectus supplement with pricing info
6:04am
8-K
EX-99.1
oeols9sctfnn6wznb
14 May 20
Windtree Therapeutics Reports First Quarter 2020 Financial Results and Provides Key Business Updates
8:12am